IGC Pharma, Inc. — Director's Dealing 2021

Sep 15, 2021

SEC Form 4/A — Form 4/A

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2021-09-15

Reporting Person: MUKUNDA RAM (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-13	COMMON STOCK	A	1000000	$0.00	Acquired	3174760	Direct
2021-05-13	COMMON STOCK	A	50000	$0.00	Acquired	777417	Indirect

Footnotes

F1: Represents restricted shares of common stock subject to vesting over three years.

F2: This Form 4 is being filed to reflect the correct ownership amount of the Reporting Person. All previous Section 16 filings of the Reporting Person since April 19, 2013 overstated the Reporting Person's ownership by 600,000 shares. Accordingly, the Reporting person owns 3,174,760 shares of Common Stock as opposed to the 3,774,760 shares previously reported on the Form 4.